|
Volumn 90, Issue 3, 2001, Pages 264-270
|
Tumor- and treatment-related side effects after multimodal therapy of childhood intracranial germ cell tumors
a a a a a a |
Author keywords
Childhood; Endocrine deficiencies; Intracranial germ cell tumors; Multimodality therapy; Side effects
|
Indexed keywords
BLEOMYCIN;
CARBOPLATIN;
CISPLATIN;
ETOPOSIDE;
HORMONE;
IFOSFAMIDE;
THIOTEPA;
VINBLASTINE;
ADOLESCENT;
ALOPECIA;
ARTICLE;
CANCER SURVIVAL;
CHILD;
CLINICAL ARTICLE;
ELECTROLYTE DISTURBANCE;
FEMALE;
FOLLOW UP;
GERM CELL TUMOR;
HEARING LOSS;
HORMONE DEFICIENCY;
HORMONE SUBSTITUTION;
HUMAN;
HUMAN TISSUE;
INTRACRANIAL TUMOR;
MALE;
MULTIMODALITY CANCER THERAPY;
NEUROOPHTHALMOLOGY;
PRIORITY JOURNAL;
PSYCHOPATHY;
QUALITY OF LIFE;
TREATMENT OUTCOME;
ADOLESCENT;
ANTINEOPLASTIC AGENTS;
BRAIN NEOPLASMS;
CHILD;
COGNITION DISORDERS;
COMBINED MODALITY THERAPY;
CRANIAL IRRADIATION;
DEAFNESS;
DEVELOPMENTAL DISABILITIES;
ENDOCRINE SYSTEM DISEASES;
EYE DISEASES;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
NEOPLASMS, GERM CELL AND EMBRYONAL;
NEUROPSYCHOLOGICAL TESTS;
PROSPECTIVE STUDIES;
TREATMENT OUTCOME;
|
EID: 0035053905
PISSN: 08035253
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1651-2227.2001.tb00302.x Document Type: Article |
Times cited : (15)
|
References (23)
|